Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
CRISPR/Cas9-based therapeutics, especially those that can correct gene mutations via homology directed repair (HDR), have the potential to revolutionize the treatment of genetic diseases. However, HDR-based therapeutics are challenging to develop because they require simultaneous in vivo delivery of Cas9 protein, guide RNA and donor DNA. Here, we demonstrate that a delivery vehicle composed of gold nanoparticles conjugated to DNA and complexed with cationic endosomal disruptive polymers can deliver Cas9 ribonucleoprotein and donor DNA into a wide variety of cell types, and efficiently correct the DNA mutation that causes Duchenne muscular dystrophy in mice via local injection, with minimal off-target DNA damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Restored muscle function was also demonstrated by increasing limb tension.[224]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [224]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“After being injected into the hindlimb muscle of mdx mice simultaneously with cardiotoxin (CTX), this system efficiently corrected the DNA mutation that causes DMD in mice with reduced off-target effect and reduced muscle fibrosis in mdx mice (Fig. 3A) [110].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [110]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Cas9 protein-sgRNA complexes can be incorporated by assembly with DNA-linked particles 78,79 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [79]
The cited source says what the claim attributes to it.
In the citing paper
“After two weeks of intramuscular injection of CRISPR-Gold with cardiotoxin in DMD mice, 5.4% of the dystrophin gene was repaired and obvious increase of dystrophin protein was observed in the treated muscle tissues.”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [224]
The cited source says what the claim attributes to it.
In the citing paper
“Lee et al. (2017) also reported use of AuNPs to deliver Cas9:sgRNA RNP to mice suffering from DMD.”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Lee et al., 2017
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116 · cited 1×
“Primarily two types of gene editing therapies are being considered for the CRISPR/Cas9 system: (1) therapies based on non-homologous end joining (NHEJ), which permanently silence disease-causing genes by inducing indel mutations, and (2) therapies based on homology directed repair (HDR), which correct disease-causing…”
BackgroundSelf-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 2×
“The experimental groups were: (1) negative control, consisting of mdx mice without injection (n = 6), (2) control (scrambled CRISPR–Gold), consisting of mice injected with CRISPR–Gold containing scrambled gRNA (n = 11), (3) CRISPR–Gold, consisting of mice injected with CRISPR–Gold containing RNP and donor DNA (n = 11)…”
MethodDetermining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863 · cited 1×
“The experimental groups were: (1) negative control, consisting of mdx mice without injection (n = 6), (2) control (scrambled CRISPR–Gold), consisting of mice injected with CRISPR–Gold containing scrambled gRNA (n = 11), (3) CRISPR–Gold, consisting of mice injected with CRISPR–Gold containing RNP and donor DNA (n = 11)…”
MethodKim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.171322.113 · Cited by 1,856
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C., & Doudna, J. A. (2014) · Nature · doi:10.1038/nature13011 · Cited by 1,822
Self-citationZuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460
Cited by
Advances in oligonucleotide drug delivery
Roberts, T. C., Langer, R., & Wood, M. J. A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0075-7 · Cited by 2,027
Li, H., Yang, Y., Hong, W., Huang, M., Wu, M., & Zhao, X. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0089-y · Cited by 1,715
“Furthermore, nonviral polymers conjugated to the gold nanoparticle hybridization system have been recognized as a suitable vehicle for the delivery of Cas9 RNP complexes plus donor DNA, which could effectively correct the disease phenotypes of muscle cells after intramuscular injection.(341)”
BackgroundCRISPR-Cas guides the future of genetic engineering
Knott, G. J., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aat5011 · Cited by 1,410
Self-citationDrug delivery systems for RNA therapeutics
Paunovska, K., Loughrey, D., & Dahlman, J. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00439-4 · Cited by 1,349
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Self-citation
Metadata
- Authors
- Lee, K., Conboy, M., Park, H. M., Jiang, F., Kim, H. J., Dewitt, M. A., Mackley, V. A., Chang, K., Rao, A., Skinner, C., Shobha, T., Mehdipour, M., Liu, H., Huang, W.-C., Lan, F., Bray, N. L., Li, S., Corn, J. E., Kataoka, K., Doudna, J. A., Conboy, I., & Murthy, N.
- Affiliations
- University of California, Berkeley (US)
- Center for Disease Biology and Integrative Medicine, The University of Tokyo (JP)
- Innovative Genomics Institute (US)
- Innovation Center of NanoMedicine (JP)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Conboy, Irina
- Murthy, Niren
- ORCID
- Venue
- Nature Biomedical Engineering
- Published
- 2017-10-02
- Volume
- 1
- Issue
- 11
- Pages
- 889-901
- ISSN
- 2157-846X (ISSN-L)
- PMC
- PMC5968829
- OpenAlex
- W2759402071
- Cited by
- 755
- References
- 46
- Citations by year
- 2026: 46 · 2025: 59 · 2024: 77 · 2023: 67 · 2022: 116 · 2021: 113 · 2020: 120 · 2019: 82 · 2018: 70 · 2017: 5
- FWCI
- 30.95
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- Japan Society for the Promotion of Science (25000006)
- National Institute on Aging (R56AG048316)
- National Institute of Allergy and Infectious Diseases (R56AI107116, R01AI088023, R01AI107116)
- National Institute of Biomedical Imaging and Bioengineering (R01EB023776)
- National Center for Research Resources (S10RR029668, S10RR027303)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- CRISPR/Cas9, homology-directed repair, gold nanoparticles, nanoparticle drug delivery, Cas9 ribonucleoprotein, donor DNA, Duchenne muscular dystrophy, gene therapy, local injection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair. https://app.cochat.ai/papers/10.1038/s41551-017-0137-2
- The paper
- Lee, K., Conboy, M., Park, H. M., Jiang, F., Kim, H. J., Dewitt, M. A., Mackley, V. A., Chang, K., Rao, A., Skinner, C., Shobha, T., Mehdipour, M., Liu, H., Huang, W.-C., Lan, F., Bray, N. L., Li, S., Corn, J. E., Kataoka, K., . . . Murthy, N. (2017). Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair. Nature Biomedical Engineering. https://doi.org/10.1038/s41551-017-0137-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.